Familial Mediterranean Fever (FMF) is a genetic autoinflammatory disease and is more commonly seen in individuals living in Mediterranean regions. This disease manifests itself through self-triggered inflammatory attacks in the body as a result of genetic mutations. The disease causes distinct attacks characterized by recurrent high fever, abdominal pain, and joint inflammation. Diagnosis is made through clinical symptoms, family history, and genetic tests. Colchicine, which is commonly used in treatment, controls the attacks, reduces inflammation, and lowers the risk of amyloidosis. However, treatment applications must be personalized.
The disease is usually diagnosed in childhood, but it is a condition that can persist throughout life. Early diagnosis is important for the effective treatment of the disease. Therefore, individuals with recurring complaints need to be monitored regularly.
What Are the Causes of Familial Mediterranean Fever (FMF)?
Familial Mediterranean Fever (FMF) has a genetic origin and is associated with mutations in the MEFV gene. This gene controls the production of an inflammation-regulating protein called pyrin. Genetic mutations occurring in FMF patients disrupt the normal function of pyrin, leading to recurrent inflammation in the body.
The disease is particularly common in certain ethnic groups living in the Mediterranean region and appears in individuals with a genetic predisposition. However, environmental triggers, factors such as infections or stress, may have an impact on the onset of the disease.
The causes of FMF involve the interaction of genetic and environmental factors, but the exact mechanism is still not fully understood.
What Are the Symptoms of Familial Mediterranean Fever (FMF)?
Familial Mediterranean Fever (FMF) is a genetic disease characterized by recurrent inflammatory attacks. The symptoms of the disease usually begin in childhood and can continue throughout life. The main symptoms of this disease are:
Recurrent High Fever: Recurrent high fever, which is prominent during FMF attacks, is a salient symptom of the disease.
Abdominal Pain: Abdominal pain arising due to inflammation of the peritoneum is among the characteristic symptoms of the disease.
Joint Pains and Swelling: FMF manifests itself with arthritis-like symptoms by causing joint pains and swelling.
Chest Pain: Chest pain resulting from pericardial inflammation during attacks is among the other symptoms of the disease.
Symptoms Associated with Amyloidosis: FMF can lead to organ damage due to protein accumulation called Amyloidosis. This condition may also be observed as a consequence of the disease.
How is Familial Mediterranean Fever (FMF) Diagnosed?
The diagnosis of Familial Mediterranean Fever (FMF) is made through the patient's symptoms, genetic testing, family history evaluation, and laboratory tests. Typical symptoms include recurrent high fever, abdominal pain, and joint pain.
Family history is important in determining the patient's genetic predisposition, and genetic tests are particularly aimed at detecting mutations in the MEFV gene. While laboratory tests help evaluate the level of inflammation in the body, immunological tests can be used to confirm the diagnosis of FMF.
The diagnosis of FMF is usually made by Rheumatology specialists and is carried out based on the patient's clinical history, symptoms, and genetic test results. This multi-method diagnostic process is important for accurately identifying the disease and establishing an effective treatment plan.
How is Familial Mediterranean Fever (FMF) Treated?
Treatment of Familial Mediterranean Fever (FMF) focuses on alleviating symptoms and preventing attacks. Colchicine is the primary medication for FMF and controls attacks by reducing inflammation. In some cases, additional anti-inflammatory drugs or immunosuppressive medications may be used.
Regular monitoring is performed against the risk of amyloidosis, and additional treatments are applied if necessary. A healthy lifestyle is part of the treatment, and regular exercise, a balanced diet, and avoiding stress support the overall health of patients.
Treatment plans are individualized and adjusted according to the patient's symptoms and health status. Patients should follow their treatment plans by maintaining regular communication with their doctor.
Special situations, such as pregnancy planning, may require the review of the treatment plan. This comprehensive treatment approach aims to improve the quality of life of FMF patients.